You can buy or sell Catabasis and other stocks, options, ETFs, and crypto commission-free!
Catabasis Pharmaceuticals, Inc. engages in the discovery, development, and commercialization of novel therapeutics. Its lead product candidate is edasalonexent, which is intended for the treatment of Duchenne muscular dystrophy. Read More The company was founded by Jill C. Milne, Michael Jirousek, and Steven Shoelson on June 26, 2008 and is headquartered in Cambridge, MA.
52 Week High
52 Week Low
Yahoo FinanceMar 19
Zacks.com featured highlights include: Catabasis, Ligand, Key, Carbonite and Second Sight
For Immediate Release Chicago, IL – March 19, 2019 - Stocks in this week’s article are Catabasis Pharmaceuticals Inc. CATB, Ligand Pharmaceuticals Inc. LGND, Key Energy Services Inc. KEG, Carbonite Inc. CARB and Second Sight Medical Products Inc. EYES. Rising P/E an Overlooked Criterion: 5 Top Stocks Trying hands at bargain stocks that have a low price-to-earnings (P/E) ratio is a common practice. The perception is that the lower the P/E, the higher will be the value of the stock. This inference is drawn...
Simply Wall StMar 15
What Kind Of Shareholders Own Catabasis Pharmaceuticals, Inc. (NASDAQ:CATB)?
The big shareholder groups in Catabasis Pharmaceuticals, Inc. (NASDAQ:CATB) have power over the company. Institutions will often hold stock in bigger companies, and we expect to see insiders owning a noticeable percentage of the smaller ones. Companies that have been privatized tend to have low insider ownership. Catabasis Pharmaceuticals is a smaller company with a market capitalization of US$65m, so it may still be flying under the radar of many institutional investors. Our analysis of the ownership of t...
Seeking AlphaMar 14
Catabasis Pharmaceuticals' (CATB) CEO Jill Milne on Q4 2018 Results - Earnings Call Transcript
Catabasis Pharmaceuticals, Inc. (NASDAQ:CATB) Q4 2018 Earnings Conference Call March 14, 2019 8:30 AM ET Company Participants Andrea Matthews – Vice President-Corporate Affairs Jill Milne – Chief Executive Officer Joanne Donovan – Chief Medical Officer Andrew Nichols – Chief Scientific Officer Noah Clauser – Vice President of Finance Conference Call Participants Hartaj Singh – Oppenheimer Joel Beatty – Citi Operator Good day, ladies and gentlemen, and welcome to the Q4 2018 Catabasis Pharmaceutic...
-$0.90 per share
-$0.85 per share